3 antibody, an anti glypican 3 antibody having a modulated plasma half life and a pharmaceutical composition comprising the antibody as an active ingredient, as well as {HEAD ~ a method} of preparing the anti glypican 3 antibody and {TAIL ~ the pharmaceutical composition} 
3 antibody , an anti glypican 3 antibody having a modulated plasma half life and a pharmaceutical composition comprising the antibody as an active ingredient , as well as { HEAD ~ a method } of preparing the anti glypican 3 antibody and { TAIL ~ the pharmaceutical composition }
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL REL OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL